Phosphate in sodium and potassium phosphates compounded injections

Importance of the topic

Compounded injections of sodium and potassium phosphates provide critical support to patients with limited or no oral intake by preventing or correcting hypophosphatemia. Accurate and reliable quantification of phosphate in these sterile solutions is essential for ensuring patient safety, maintaining therapeutic efficacy, and complying with regulatory standards such as those of the United States Pharmacopeia (USP).

Objectives and study overview

This study aimed to validate an ion chromatography assay using a Metrosep A Supp 17 column with alternative L91 packing material for quantifying phosphate in compounded injections of sodium and potassium phosphates. The work was conducted in cooperation with the USP to demonstrate column equivalency and meet General Chapter <621> requirements.

Methodology and instrumentation

The assay employed suppressed conductivity detection after isocratic separation on the Metrosep A Supp 17 150/4.0 column. Key instrument components included:

• 930 Compact IC Flex with column oven, sequential suppression, peristaltic pump, and integrated degasser
• 919 IC Autosampler plus for automated sample handling
• IC Conductivity Detector with high temperature stability and dynamic range

Eluent was 40 mmol/L sodium hydroxide at 1.0 mL/min, column temperature 30 °C, and injection volume 10 µL. Sample stock solutions were prepared from monobasic and dibasic phosphate salts in sterile water, diluted to a nominal 0.23 mg/mL phosphate concentration. A single-point calibration at 0.230 mg/mL phosphate was used.

Main results and discussion

The method achieved recoveries of 98–99 % for phosphate in both sodium and potassium formulations, with high reproducibility (RSD < 0.3 %) and symmetric peaks eluting at approximately 6 minutes (tailing factor 1.59–1.60). All system suitability criteria defined by USP were met, confirming the robustness and reliability of the alternative column packing.

Benefits and practical applications

• Ensures precise phosphate dosing in sterile compounded injections for clinical use
• Meets stringent USP validation criteria for quality control
• Simplifies method transfer by using widely available Metrosep A Supp 17 columns
• Supports routine analysis in hospital and industrial laboratories

Future trends and opportunities

Advances may include coupling ion chromatography with mass spectrometry for enhanced sensitivity and specificity, exploring greener eluent systems to reduce environmental impact, and integrating inline dilution for higher throughput. Continuous improvements in column materials and suppression technology will further optimize assay performance.

Conclusion

The validated ion chromatography method using a Metrosep A Supp 17 column offers a robust, precise, and USP-compliant approach for quantifying phosphate in sodium and potassium phosphate compounded injections. It provides essential quality control for compounded sterile preparations in clinical and industrial settings.

Reference

1. United States Pharmacopeia. Sodium Phosphates Injection monograph, DailyMed, 2022.
2. United States Pharmacopeia. Sodium Phosphates Compounded Injection monograph.
3. United States Pharmacopeia. Potassium Phosphates Compounded Injection monograph.
4. United States Pharmacopeia General Chapter <621> Chromatography.